Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Nishimura, K.
Right arrow Articles by Nishibuchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimura, K.
Right arrow Articles by Nishibuchi, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 18:217-226 (1988)
© 1988 Foundation for Promotion of Cancer Research


research-article

The Validity of Magnetic Resonance Imaging (MRI) in the Staging of Bladder Cancer: Comparison with Computed Tomography (CT) and Transurethral Ultrasonography (US)

Kazuo Nishimura, M.D1, Shuichi Hida, M.D1, Yasunori Nishio, M.D1, Kenji Ohishi, M.D1, Yusaku Okada, M.D1, Kenichiro Okada, M.D1, Osamu Yoshida, M.D*,1, Kazumasa Nishimura, M.D2 and Shigeo Nishibuchi, M.D3

1Department of Urology, Kyoto University 54, Kawara-machi, Shogoin, Sakyo-ku, Kyoto 606
2Department of Nuclear Medicine, Faculty of Medicine, Kyoto University 54, Kawara-machi, Shogoin, Sakyo-ku, Kyoto 606
3Department of Urology, Kyoto Senbai Hospital Kyoto

*For reprints and all correspondence.

Received January 27, 1988; accepted April 21, 1988

The magnetic resonance imaging (MRI) of bladder cancer was accomplished in 26 patients who had histologically proven transitional cell carcinoma through transurethral resection. All 26 patients were simultaneously studied by computed tomography (CT) and 21 were also studied by transurethral ultrasonography (US) before surgery or preoperative irradiation. The evaluations of the MRI and CT were carried out by the same radiologist and urologist postoperatively; the evaluation of the US was carried out by several urologists preoperatively, and their results compared with the postoperative pathological findings. The staging accuracy for pT2 tumors and above for each imaging modality was as follows. MRI: sensitivity 83.3%, specificity 71.4%, accuracy 76.9%; CT: sensitivity 58.3%, specificity 42.8%, accuracy 50%; US: sensitivity 100%, specificity 70%, accuracy 85.7%. The results of the staging with regard to extravesical extensions were as follows. MRI: sensitivity 60%, specificity 85.7%, accuracy 80.8%; CT: sensitivity 60%, specificity 81%, accuracy 76.9%. On the other hand, the sensitivity of US was 25%, specificity 94.1% and accuracy was 81%. The higher the pathological staging, the more the diagnostic accuracy was likely to be increased with MRI and CT, but diminished for US. There were three case of pT1 tumors being over-diagnosed by US, but two of them were accurately staged by MRI. The other 11 cases, diagnosed as T2 or above by US, were only minimally overstaged or understaged by MRI. MRI seemed able to overcome the disadvantage of US which tended to over-diagnose pT1 tumors and which was not suitable for use in diagnosing infil-trative tumors correctly. CT seemed useless for local staging.

Key Words: MRI • Bladder cancer • Staging


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
E. Ozden, A. T. Turgut, M. Yesil, C. Gogus, and O. Gogus
A New Parameter for Staging Bladder Carcinoma: Ultrasonographic Contact Length and Height-to-Length Ratio
J. Ultrasound Med., September 1, 2007; 26(9): 1137 - 1142.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.